X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs WOCKHARDT LTD. - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA WOCKHARDT LTD. SANOFI INDIA/
WOCKHARDT LTD.
 
P/E (TTM) x 30.7 16.8 182.8% View Chart
P/BV x 5.4 1.7 316.4% View Chart
Dividend Yield % 1.7 0.0 -  

Financials

 SANOFI INDIA   WOCKHARDT LTD.
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
WOCKHARDT LTD.
Mar-16
SANOFI INDIA/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs4,5602,000 228.0%   
Low Rs4,400706 623.4%   
Sales per share (Unadj.) Rs1,028.5403.7 254.8%  
Earnings per share (Unadj.) Rs129.029.5 437.6%  
Cash flow per share (Unadj.) Rs186.042.4 438.9%  
Dividends per share (Unadj.) Rs68.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs753.6323.4 233.0%  
Shares outstanding (eoy) m23.03110.51 20.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.43.4 130.0%   
Avg P/E ratio x34.745.9 75.7%  
P/CF ratio (eoy) x24.131.9 75.4%  
Price / Book Value ratio x5.94.2 142.1%  
Dividend payout %52.70-   
Avg Mkt Cap Rs m103,174149,509 69.0%   
No. of employees `0003.67.4 49.1%   
Total wages/salary Rs m3,5929,443 38.0%   
Avg. sales/employee Rs Th6,537.76,048.6 108.1%   
Avg. wages/employee Rs Th991.41,280.2 77.4%   
Avg. net profit/employee Rs Th819.8441.5 185.7%   
INCOME DATA
Net Sales Rs m23,68644,614 53.1%  
Other income Rs m708970 73.0%   
Total revenues Rs m24,39445,584 53.5%   
Gross profit Rs m5,2815,038 104.8%  
Depreciation Rs m1,3131,426 92.1%   
Interest Rs m151,012 1.5%   
Profit before tax Rs m4,6613,570 130.6%   
Minority Interest Rs m0-65 0.0%   
Prior Period Items Rs m06 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,691255 663.7%   
Profit after tax Rs m2,9703,257 91.2%  
Gross profit margin %22.311.3 197.4%  
Effective tax rate %36.37.1 508.3%   
Net profit margin %12.57.3 171.8%  
BALANCE SHEET DATA
Current assets Rs m15,67339,906 39.3%   
Current liabilities Rs m6,67818,423 36.2%   
Net working cap to sales %38.048.2 78.9%  
Current ratio x2.32.2 108.4%  
Inventory Days Days7690 84.3%  
Debtors Days Days2298 22.7%  
Net fixed assets Rs m8,09835,832 22.6%   
Share capital Rs m230553 41.7%   
"Free" reserves Rs m17,08830,370 56.3%   
Net worth Rs m17,35635,739 48.6%   
Long term debt Rs m016,542 0.0%   
Total assets Rs m25,40079,522 31.9%  
Interest coverage x311.74.5 6,885.5%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.90.6 166.2%   
Return on assets %11.85.4 218.9%  
Return on equity %17.19.1 187.8%  
Return on capital %26.98.7 311.4%  
Exports to sales %24.511.6 211.1%   
Imports to sales %28.04.5 627.2%   
Exports (fob) Rs m5,8015,177 112.1%   
Imports (cif) Rs m6,6271,990 333.0%   
Fx inflow Rs m7,1457,589 94.2%   
Fx outflow Rs m6,8462,878 237.8%   
Net fx Rs m2994,711 6.3%   
CASH FLOW
From Operations Rs m3,226716 450.5%  
From Investments Rs m-1,555-8,182 19.0%  
From Financial Activity Rs m-1,8182,543 -71.5%  
Net Cashflow Rs m-147-4,923 3.0%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 2.3 626.1%  
FIIs % 14.6 7.7 189.6%  
ADR/GDR % 0.0 0.1 -  
Free float % 10.5 15.4 68.2%  
Shareholders   15,184 67,757 22.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   FULFORD INDIA  VENUS REMEDIES  STERLING BIOTECH  CADILA HEALTHCARE  AUROBINDO PHARMA  

Compare SANOFI INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Red; Infosys Tanks as CEO Vishal Sikka Resigns(09:30 am)

Asian indices are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.2%, while the Hang Seng is down 0.7%. The Nikkei 225 is trading lower by 0.9%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Aug 17, 2017 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS